These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8740782)

  • 1. Effects of adjuvant systemic treatments in breast cancer.
    Valagussa P; Bonadonna G
    Ann Oncol; 1996 Mar; 7(3):221-2. PubMed ID: 8740782
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac effects following adjuvant chemotherapy and breast irradiation in operable breast cancer.
    Valagussa P; Zambetti M; Biasi S; Moliterni A; Zucali R; Bonadonna G
    Ann Oncol; 1994 Mar; 5(3):209-16. PubMed ID: 8186169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant systemic therapy for breast cancer.
    Roy JA; Piccart MJ
    Curr Opin Oncol; 1995 Nov; 7(6):517-22. PubMed ID: 8547399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Problems with the evaluation of response after induction chemotherapy in breast cancer.
    Mannesse CK; van Pel R; van Spengler J; van Eijck CH; Splinter TA
    Eur J Cancer; 1995 Oct; 31A(11):1886-7. PubMed ID: 8541121
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant systemic therapy for breast cancer.
    Harris DT
    Semin Oncol; 1995 Dec; 22(6):553-70. PubMed ID: 8539632
    [No Abstract]   [Full Text] [Related]  

  • 6. Adjuvant systemic therapy for breast cancer.
    Piccart MJ; Biganzoli L; Roy JA
    Curr Opin Oncol; 1996 Nov; 8(6):478-84. PubMed ID: 8971467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant versus adjuvant systemic therapy for operable breast cancer: equivalent outcomes?
    Smith BL
    Ann Surg; 2013 Feb; 257(2):180-1. PubMed ID: 23291659
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent advances in adjuvant systemic therapy for early-stage breast cancer.
    Bedard PL; Cardoso F
    Ann Oncol; 2008 Jul; 19 Suppl 5():v122-7. PubMed ID: 18611869
    [No Abstract]   [Full Text] [Related]  

  • 9. [Systemic adjuvant therapy of breast cancer: myths and controversies].
    Roy JA; Piccart MJ
    Rev Med Brux; 1996 Sep; 17(4):267-70. PubMed ID: 8927859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of adjuvant chemotherapy in stage II breast cancer in the last 25 years--a brief review].
    Sulkes A
    Harefuah; 2002 Apr; 141(4):374-8, 408. PubMed ID: 12017895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized clinical trial of adjuvant fluorouracil, epirubicin, and cyclophosphamide chemotherapy for patients with fast-proliferating, node-negative breast cancer.
    Paradiso A; Schittulli F; Cellamare G; Mangia A; Marzullo F; Lorusso V; De Lena M
    J Clin Oncol; 2001 Oct; 19(19):3929-37. PubMed ID: 11579113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of young women with high-risk breast cancer for adjuvant systemic therapy.
    Stoll BA
    Clin Oncol (R Coll Radiol); 1992 Jan; 4(1):48-50. PubMed ID: 1736981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent trends in the management of breast cancer. 3. Controversies in the use of adjuvant chemotherapy, hormonotherapy and radiotherapy for breast cancer.
    Donegan WL
    Can J Surg; 1992 Aug; 35(4):371-7. PubMed ID: 1498737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical practice guidelines for the care and treatment of breast cancer: adjuvant systemic therapy for node-positive breast cancer (summary of the 2001 update). The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
    Levine M;
    CMAJ; 2001 Mar; 164(5):644-6. PubMed ID: 11258212
    [No Abstract]   [Full Text] [Related]  

  • 15. The new millennium for adjuvant therapy in breast cancer.
    Sledge GW
    Oncology (Williston Park); 2008 May; 22(6):598-602; discussion 602-3, 606, 608. PubMed ID: 18561550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A prospective randomized study of intra-arterial infusion chemotherapy in the treatment of advanced breast cancer].
    Takatsuka Y; Yayoi E; Kobayashi T; Aikawa T; Kotsuma Y
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1617-20. PubMed ID: 1530319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cosmesis, late sequelae and local control after breast-conserving therapy: influence of type of tumour bed boost and adjuvant chemotherapy.
    Budrukkar AN; Sarin R; Shrivastava SK; Deshpande DD; Dinshaw KA
    Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):596-603. PubMed ID: 17706403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncoplastic breast surgery does not delay the onset of adjuvant chemotherapy: a population-based study.
    Klit A; Tvedskov TF; Kroman N; Elberg JJ; Ejlertsen B; Henriksen TF
    Acta Oncol; 2017 May; 56(5):719-723. PubMed ID: 28162018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncoplastic breast conservation does not lead to a delay in the commencement of adjuvant chemotherapy in breast cancer patients.
    Khan J; Barrett S; Forte C; Stallard S; Weiler-Mithoff E; Doughty JC; Romics L
    Eur J Surg Oncol; 2013 Aug; 39(8):887-91. PubMed ID: 23746877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-Varying Effects of Breast Cancer Adjuvant Systemic Therapy.
    Jatoi I; Bandos H; Jeong JH; Anderson WF; Romond EH; Mamounas EP; Wolmark N
    J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26518884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.